S. Boselli

Vatalanib for metastatic gastrointestinal stromal tumour (GIST) resistant to imatinib: final results of a phase II study

Heikki Joensuu, Filippo de Braud, G Grignagni et al. · British Journal of Cancer · 2011 · 77 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase I Study of NGR-hTNF, a Selective Vascular Targeting Agent, in Combination with Cisplatin in Refractory Solid Tumors

Vanesa Gregorc, Filippo de Braud, Tommaso Martino De Pas et al. · Clinical Cancer Research · 2011 · 54 citations

Medicine, Oncology, Pharmacology +17

Preoperative versus postoperative docetaxel–cisplatin–fluorouracil (TCF) chemotherapy in locally advanced resectable gastric carcinoma: 10-year follow-up of the SAKK 43/99 phase III trial

Nicola Fazio, Roberto Biffi, Rudolf Maibach et al. · Annals of Oncology · 2015 · 48 citations · Full text

Medicine, Oncology, Surgery +8

First clinical experience of orally active epidermal growth factor receptor inhibitor combined with simplified FOLFOX6 as first‐line treatment for metastatic colorectal cancer

Maria Giulia Zampino, Elena Magni, Cristian Massacesi et al. · Cancer · 2007 · 37 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

First-line gefitinib combined with simplified FOLFOX-6 in patients with epidermal growth factor receptor-positive advanced colorectal cancer

Maria Giulia Zampino, K. Lorizzo, Cristian Massacesi et al. · Journal of Clinical Oncology · 2005 · 23 citations

Medicine, Pharmacology, Pharmacotherapy +15